NOK/STYK1 interacts with GSK‐3β and mediates Ser9 phosphorylation through activated Akt
Authors:
- Fang WuFWFang Wu
- Feng ShengFSFeng Sheng
- Yi-Jia LiYLYi-Jia Li
- Da JinDJDa Jin
- Xue DingXDXue Ding
- Shuping ZhangSZShuping Zhang
- 23 September 2012
- journal article
- Published by Wiley in FEBS Letters
- Vol. 586 (21) , 3787-3792
Abstract
GSK3B physically interacts with NOK by anti tag coimmunoprecipitation (View interaction).Keywords
Funding Information
- National Natural Science Foundation of China (81072167, 30921004)
This publication has 30 references indexed in Scilit:
- NOK/STYK1 has a strong tendency towards forming aggregates and colocalises with epidermal growth factor receptor in endosomesBiochemical and Biophysical Research Communications, 2012
- Epithelial–Mesenchymal Transition in Mouse Mammary TumorigenesisFuture Oncology, 2009
- Aberrant STYK1 expression in ovarian cancer tissues and cell linesJournal of Ovarian Research, 2009
- Overexpression of the potential kinase serine/ threonine/tyrosine kinase 1 (STYK 1) in castration‐resistant prostate cancerCancer Science, 2009
- Overexpression of serine threonine tyrosine kinase 1/novel oncogene with kinase domain mRNA in patients with acute leukemiaExperimental Hematology, 2009
- Diagnostic relevance of overexpressed mRNA of novel oncogene with kinase-domain (NOK) in lung cancersLung Cancer, 2007
- Point Mutation at Single Tyrosine Residue of Novel Oncogene NOK Abrogates Tumorigenesis in Nude MiceCancer Research, 2005
- A Novel Protein Tyrosine Kinase NOK that Shares Homology with Platelet- Derived Growth Factor/Fibroblast Growth Factor Receptors Induces Tumorigenesis and Metastasis in Nude MiceCancer Research, 2004
- Epithelial–mesenchymal transitions in tumour progressionNature Reviews Cancer, 2002
- Cell Signaling by Receptor Tyrosine KinasesCell, 2000